Back

Cancer-associated Fibroblast Spatial Heterogeneity and EMILIN1 Expression in Cancer Stroma Modulate TGF-beta Activity and CD8+ T-Cell Infiltration in Breast Cancer

Honda, C.; Kurozumi, S.; Fujii, T.; Pourquier, D.; Khellaf, L.; Boissiere, F.; Horiguchi, J.; Oyama, T.; Shirabe, K.; Colinge, J.; Yokobori, T.; Turtoi, A.

2023-09-15 cancer biology
10.1101/2023.09.12.557312 bioRxiv
Show abstract

The tumor microenvironment (TME) and its multifaceted interactions with cancer cells are major targets for cancer treatment. Single-cell technologies have brought major insights into the TME, but the resulting complexity frequently precludes conclusions on function. Therefore, we combined single-cell RNA sequencing and spatial transcriptomic data to explore the relationship between different cancer-associated fibroblast (CAF) populations and immune cell exclusion in breast tumors. Our data show for the first time the degree of spatial organization of different CAF populations in breast cancer. We found that IL-iCAFs, Detox-iCAFs, and IFN{gamma}-iCAFs tended to cluster together, while Wound-myCAFs, TGF{beta}-myCAFs, and ECM-myCAFs formed another group that overlapped with elevated TGF-{beta} signaling. Differential gene expression analysis of areas with CD8+ T-cell infiltration/exclusion within the TGF-{beta} signaling-rich zones identified elastin microfibrillar interface protein 1 (EMILIN1) as a top modulated gene. EMILIN1, a TGF-{beta} inhibitor, was upregulated in IFN{gamma}-iCAFs directly modulating TGF{beta} immunosuppressive function. Histological analysis of 74 breast cancer samples confirmed that high EMILIN-1 expression in the tumor margins was related to high CD8+ T-cell infiltration, consistent with our spatial gene expression analysis. High EMILIN-1 expression was also associated with better prognosis of patients with breast cancer, underscoring its functional significance for the recruitment of cytotoxic T cells into the tumor area. In conclusion, our data show that correlating TGF-{beta} signaling to a CAF subpopulation is not enough because proteins with TGF-{beta}-modulating activity originating from other CAF subpopulations can alter its activity. Therefore, therapeutic targeting should remain focused on biological processes rather than on specific CAF subtypes.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Cancers
200 papers in training set
Top 0.4%
10.0%
2
Cancer Research
116 papers in training set
Top 0.1%
8.1%
3
Breast Cancer Research
32 papers in training set
Top 0.1%
6.3%
4
Cell Reports
1338 papers in training set
Top 8%
6.3%
5
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.1%
4.3%
6
Frontiers in Immunology
586 papers in training set
Top 2%
3.6%
7
Scientific Reports
3102 papers in training set
Top 38%
3.6%
8
Molecular Oncology
50 papers in training set
Top 0.2%
2.6%
9
Nature Communications
4913 papers in training set
Top 45%
2.4%
10
OncoImmunology
22 papers in training set
Top 0.1%
2.1%
11
Genome Medicine
154 papers in training set
Top 3%
2.1%
50% of probability mass above
12
International Journal of Cancer
42 papers in training set
Top 0.5%
2.1%
13
Cell Communication and Signaling
35 papers in training set
Top 0.3%
2.1%
14
iScience
1063 papers in training set
Top 12%
1.9%
15
PLOS Computational Biology
1633 papers in training set
Top 16%
1.7%
16
Cancer Immunology Research
34 papers in training set
Top 0.3%
1.7%
17
Cell Death & Disease
126 papers in training set
Top 1%
1.7%
18
The Journal of Pathology
22 papers in training set
Top 0.2%
1.5%
19
Frontiers in Oncology
95 papers in training set
Top 3%
1.3%
20
Cell Reports Medicine
140 papers in training set
Top 5%
1.3%
21
Cancer Research Communications
46 papers in training set
Top 0.6%
1.3%
22
Communications Biology
886 papers in training set
Top 13%
1.3%
23
Oncogene
76 papers in training set
Top 1%
1.2%
24
JCI Insight
241 papers in training set
Top 5%
1.2%
25
npj Breast Cancer
18 papers in training set
Top 0.1%
1.2%
26
npj Precision Oncology
48 papers in training set
Top 0.9%
1.1%
27
Cell Death Discovery
51 papers in training set
Top 1.0%
0.9%
28
PLOS ONE
4510 papers in training set
Top 63%
0.9%
29
eLife
5422 papers in training set
Top 52%
0.9%
30
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.9%